title: Response to Contraception Letter to the Editor (CONTRACEPTION_2015_94).
authors.affiliation: Division of Clinical Pharmacology 3, Office of Clinical Pharmacology, Office of Translational Sciences, Center of Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, MD 20993, USA.
authors.forename: Michiyo
authors.initials: M
authors.lastname: Yamazaki
authors.affiliation: Division of Biostatistics 3, Office of Biostatistics, Office of Translational Sciences, Center of Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, MD 20993, USA.
authors.forename: Kate
authors.initials: K
authors.lastname: Dwyer
authors.affiliation: Division of Biostatistics 3, Office of Biostatistics, Office of Translational Sciences, Center of Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, MD 20993, USA.
authors.forename: Mahboob
authors.initials: M
authors.lastname: Sobhan
authors.affiliation: Division of Bone, Reproductive, and Urologic Products, Office of New Drugs, Center of Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, MD 20993, USA.
authors.forename: Daniel
authors.initials: D
authors.lastname: Davis
authors.affiliation: Division of Clinical Pharmacology 3, Office of Clinical Pharmacology, Office of Translational Sciences, Center of Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, MD 20993, USA.
authors.forename: Myong-Jin
authors.initials: MJ
authors.lastname: Kim
authors.affiliation: Division of Bone, Reproductive, and Urologic Products, Office of New Drugs, Center of Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, MD 20993, USA.
authors.forename: Lisa
authors.initials: L
authors.lastname: Soule
authors.affiliation: Division of Bone, Reproductive, and Urologic Products, Office of New Drugs, Center of Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, MD 20993, USA.
authors.forename: Gerald
authors.initials: G
authors.lastname: Willett
authors.affiliation: Division of Clinical Pharmacology 3, Office of Clinical Pharmacology, Office of Translational Sciences, Center of Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, MD 20993, USA. Electronic address: chongwoo.yu@fda.hhs.gov.
authors.forename: Chongwoo
authors.initials: C
authors.lastname: Yu
mesh_terms: D003278:Contraceptives, Oral, Hormonal; D005260:Female; D006801:Humans; D009765:Obesity; D011247:Pregnancy
chemical_list: D003278:Contraceptives, Oral, Hormonal